hepatitis C

;

Letter in support of HIV and hepatitis provisions in the “Restoring Hope for Mental Health and Well-Being Act of 2022” (H.R. 7666)

May 10, 2022

The HIV+Hepatitis Policy Institute, a national, non-profit organization whose mission is to promote quality and affordable healthcare for people living with or at risk of HIV, hepatitis, and other serious and chronic health conditions, is pleased to offer comments in support of the HIV and viral hepatitis provisions included in the “Restoring Hope for Mental Health and Well-Being Act of 2022” (HR 7666). This bipartisan bill introduced by Chairman Frank Pallone and Ranking Member Cathy McMorris Rodgers reauthorizes key Substance Abuse and Mental Health Services Administration (SAMHSA) and Health Resources and Services Administration (HRSA) programs to address the national mental health and substance use disorder crises. The subcommittee is expected to consider the bill tomorrow.

read more

Comments on draft hepatitis federal implementation plan

Nov 19, 2021

We cannot achieve the goal of ending hepatitis without increased funding for the key elements of the strategy, including testing, treating, and vaccination. Increasing resources for hepatitis elimination must be our first priority. While this draft hepatitis federal implementation plan was drafted with current resources in mind, there are areas where we would suggest some strengthening.

read more

Letter to Tamara Jensen on Medicare NCD Update for Hepatitis C Screening

Jun 2, 2021

The HIV+Hepatitis Policy Institute and others are requesting that CMS update the HCV screening National Coverage Determination to bring it in line with the 2020 U.S. Preventive Services Task Force recommendation for HCV screening. The current coverage determination only requires Medicare coverage for HCV screening of baby boomers and people at high risk. We are requesting that Medicare should cover screening of everyone between the ages of 18-79, regardless of symptoms or risk group.

read more

Search

Categories

Tags

ACA Appropriations Biden administration CDC co-pay accumulators Congress copay copay accumulator Copay accumulators Copay assistance Cost-sharing COVID-19 Drug Pricing FDA Gay men healthcare Hepatitis Hepatitis B hepatitis C Hepatitis Prevention HHS HIV HIV Prevention Insurers Medicaid medicare Medicare Part D NAIC NIH PBM PBMs PrEP Prescription Drugs Private Insurance Ryan White Program state STDs Syringe services Testing transparency Treatment Trump administration women

Recent Testimony, Letters, Comments

Pin It on Pinterest